These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34557195)

  • 41. Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.
    Zhao H; Kurbanov F; Wan MB; Yin YK; Niu JQ; Hou JL; Wei L; Wang GQ; Tanaka Y; Mizokami M; Si CW
    Clin Infect Dis; 2007 Feb; 44(4):541-8. PubMed ID: 17243057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
    Zhu S; Zhang H; Dong Y; Wang L; Xu Z; Liu W; Gan Y; Tang H; Chen D; Wang F; Zhao P
    J Hepatol; 2018 Jun; 68(6):1123-1128. PubMed ID: 29452204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy.
    Huang Z; Ge J; Pang J; Liu H; Chen J; Liao B; Huang X; Zuo D; Sun J; Lu M; Zhang X; Hou J
    Antiviral Res; 2015 Jun; 118():10-9. PubMed ID: 25771704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation.
    Mitra B; Wang J; Kim ES; Mao R; Dong M; Liu Y; Zhang J; Guo H
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
    Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
    J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
    You J; Zhuang L; Cheng HY; Yan SM; Yu L; Huang JH; Tang BZ; Huang ML; Ma YL; Chongsuvivatwong V; Sriplung H; Geater A; Qiao YW; Wu RX
    World J Gastroenterol; 2006 Nov; 12(41):6715-21. PubMed ID: 17075991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.
    Chen J; Yuan Z
    Virol Sin; 2014 Feb; 29(1):17-24. PubMed ID: 24452540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.
    Chen M; Hu P; Ling N; Peng H; Lei Y; Hu H; Zhang D; Ren H
    PLoS One; 2015; 10(3):e0120086. PubMed ID: 25774808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan.
    Hsu HY; Tsai HY; Wu TC; Chiang CL; Ni YH; Chen PJ; Chang MH
    Liver Int; 2008 Nov; 28(9):1288-97. PubMed ID: 18397229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
    Koh S; Bertoletti A
    Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.
    Buster EH; Hansen BE; Lau GK; Piratvisuth T; Zeuzem S; Steyerberg EW; Janssen HL
    Gastroenterology; 2009 Dec; 137(6):2002-9. PubMed ID: 19737568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of innate immunity in the immunopathology and treatment of HBV infection.
    Maini MK; Gehring AJ
    J Hepatol; 2016 Apr; 64(1 Suppl):S60-S70. PubMed ID: 27084038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
    Wang K; Fan X; Fan Y; Wang B; Han L; Hou Y
    J Viral Hepat; 2007 Apr; 14(4):276-82. PubMed ID: 17381720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of pegylated interferon-α2a in chronic hepatitis B patients demonstrating a spontaneous decline in HBV DNA after acute exacerbation.
    Cai Q; Chen F; Shao X; Zhang X; Zhao Z; Gao Z
    Antivir Ther; 2015; 20(2):217-24. PubMed ID: 25138110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.
    Limothai U; Chuaypen N; Poovorawan K; Chotiyaputta W; Tanwandee T; Poovorawan Y; Tangkijvanich P
    J Viral Hepat; 2019 Dec; 26(12):1481-1488. PubMed ID: 31446638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peginterferon α in the treatment of chronic hepatitis B.
    Tseng TC; Kao JH; Chen DS
    Expert Opin Biol Ther; 2014 Jul; 14(7):995-1006. PubMed ID: 24738850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Interferon in hepatitis B].
    García Buey L; González Mateos F; Moreno Otero R
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():19-31. PubMed ID: 19100228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection.
    Aspord C; Bruder Costa J; Jacob MC; Dufeu-Duchesne T; Bertucci I; Pouget N; Brevot-Lutton O; Zoulim F; Bourliere M; Plumas J; Leroy V;
    PLoS One; 2016; 11(6):e0156200. PubMed ID: 27281019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.